Levosimendan to Facilitate Weaning From ECMO in Patients With Severe Cardiogenic Shock

Journal:

JAMA: The Journal of the American Medical Association

Published:

2025-12-02

DOI:

10.1001/jama.2025.19843

Affiliations:

26

Authors:

72

Go to article

Institutions	Authors	Share
AP-HP Pitié-Salpêtrière Hospital, France	4.166667	0.25
Institute of Cardiometabolism and Nutrition (ICAN), France	2.000000	0.12
Georges Pompidou European Hospital (HEGP), France	1.000000	0.06
Physiology and Experimental Medicine: Heart - Muscles (PHYMEDEXP), France	1.000000	0.06
Centre d'Investigation Clinique de Rennes (CIC de Rennes), France	1.000000	0.06
Biology of Cardiovascular Diseases, France	1.000000	0.06
CHU de Bordeaux, France	1.000000	0.06
Cardiovascular, Metabolism, Diabetes, and Nutrition (CarMeN Laboratory), France	0.500000	0.03
Hôpital Louis Pradel, France	0.500000	0.03
Bichat-Claude Bernard Hospital, France	0.500000	0.03
Sorbonne University, France	0.500000	0.03
University of Lille (UDL), France	0.500000	0.03
Centre Hospitalier Universitaire de Lille (CHU Lille), France	0.500000	0.03
Infection, Antimicrobials, Modelling, Evolution (IAME), France	0.500000	0.03
Défaillance Cardio-Vasculaire Aigüe et Chronique (DCAC), France	0.333333	0.02
Institut du Thorax (IdT), France	0.333333	0.02
Pierre Louis Institute of Epidemiology and Public Health (iPLESP), France	0.333333	0.02
Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy), France	0.333333	0.02
University Hospital Nantes (CHU de Nantes), France	0.333333	0.02
University of Nantes, France	0.333333	0.02
University of Lorraine (UL), France	0.333333	0.02

Interested in Cardiovascular Medicine and Haematology?